Exhibit 3.1
Execution Version
HARPOON THERAPEUTICS, INC.
CERTIFICATE OF DESIGNATION OF PREFERENCES,
RIGHTS AND LIMITATIONS
OF
8.000% SERIES A REDEEMABLE PREFERRED STOCK
PURSUANT TO SECTION 151 OF THE
DELAWARE GENERAL CORPORATION LAW
The undersigned, Julie Eastland, does hereby certify that:
1. Julie Eastland is the Chief Executive Officer of Harpoon Therapeutics, Inc., a Delaware corporation (the “Corporation”).
2. The Corporation is authorized to issue 10,000,000 shares of preferred stock, $0.0001 par value per share.
3. The following resolutions were duly adopted by the board of directors of the Corporation (the “Board of Directors”), upon recommendation by a committee of the Board of Directors comprised of independent and disinterested directors acting under authority delegated by the Board of Directors:
WHEREAS, the amended and restated certificate of incorporation of the Corporation, as amended (the “Certificate of Incorporation”), provides for a class of its authorized stock known as preferred stock, consisting of 10,000,000 shares, $0.0001 par value per share (the “Preferred Stock”), issuable from time to time in one or more series;
WHEREAS, the Board of Directors is authorized to provide for the issue of all or any wholly unissued series of Preferred Stock and the number of shares constituting any series and the designation thereof, and to fix the number of shares and to determine or alter for each such series, such voting powers, full or limited, or no voting powers, and such designation, preferences, and relative, participating, optional, or other rights and such qualifications, limitations, or restrictions thereof; and
WHEREAS, it is the desire of the Board of Directors, pursuant to its authority as aforesaid, to fix the rights, preferences, restrictions and other matters relating to a series of the Preferred Stock having a par value of $0.0001 per share, designated as Series A Redeemable Preferred Stock:
NOW, THEREFORE, BE IT RESOLVED that, pursuant to the authority granted to and vested in the Board of Directors in accordance with applicable law and the provisions of the Certificate of Incorporation, the Board of Directors hereby creates, authorizes and provides for 25,000 shares of the Corporation’s authorized Preferred Stock to be designated and issued as the “Series A Redeemable Preferred Stock,” having the relative rights, powers, preferences and limitations that are set forth as follows:
Section 1. Definitions. For the purposes hereof, the following terms shall have the following meanings:
“Accreted Value” shall mean, with respect to each share of Series A Preferred Stock, the Stated Value plus all Accrued Dividends.